Breaking News Instant updates and real-time market news.

CPB

Campbell Soup

$42.17

-0.95 (-2.20%)

, AGN

Allergan

$163.70

0.08 (0.05%)

18:24
03/21/18
03/21
18:24
03/21/18
18:24

Campbell Soup appoints Maria Teresa Hilado as director

Campbell Soup (CPB) announced that the company's Board of Directors has elected Maria Teresa Hilado as a member of the Board, effective March 21. Hilado has more than 30 years of experience in finance and treasury with several leading multinational companies across a variety of industries. She recently retired from global pharmaceutical company Allergan (AGN) after serving as Executive Vice President and CFO from Dec. 2014 to Feb. 2018. Previously, she served as Senior Vice President of Finance and Treasurer for PepsiCo (PEP) for five years. Earlier in her career, Hilado spent more than 17 years with General Motors (GM) in leadership roles of increasing responsibility, most notably Assistant Treasurer, and CFO, GMAC Commercial Finance LLC. She began her career with Far East Bank & Trust Co., in Manila, Philippines.

CPB

Campbell Soup

$42.17

-0.95 (-2.20%)

AGN

Allergan

$163.70

0.08 (0.05%)

PEP

PepsiCo

$108.74

-1.16 (-1.06%)

GM

General Motors

$37.58

0.69 (1.87%)

  • 25

    Mar

  • 05

    Apr

  • 24

    Apr

  • 30

    May

CPB Campbell Soup
$42.17

-0.95 (-2.20%)

02/06/18
JEFF
02/06/18
DOWNGRADE
Target $50
JEFF
Hold
Snyder's-Lance downgraded to Hold from Buy at Jefferies
Jefferies analyst Akshay Jagdale downgraded Snyder's-Lance (LNCE) to Hold citing the acquisition by Campbell Soup (CPB). The chance of a higher, alternative bid emerging is "fairly remote" given the transaction's rich valuation, Jagdale tells investors in a research note. The analyst raised his price target for the shares to $50 from $44 and expects the deal to close in Q2.
02/28/18
PIPR
02/28/18
DOWNGRADE
PIPR
Underweight
Campbell Soup downgraded to Underweight from Neutral at Piper Jaffray
03/01/18
PIPR
03/01/18
DOWNGRADE
Target $45
PIPR
Underweight
Campbell Soup downgraded to Underweight from Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery downgraded Campbell Soup to Underweight and lowered his price target for the shares to $45 from $53. The analyst sees multiple expansion as unlikely given his expectations for 1.0%-1.5% earnings growth in fiscal 2019. Higher interest rates and lower than expected Snyder-Lance operating contribution weigh on the analyst's earnings expectations.
03/01/18
03/01/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Campbell Soup (CPB) downgraded to Underweight from Neutral at Piper Jaffray by analyst Michael Lavery, who sees multiple expansion as unlikely given his expectations for 1%-1.5% earnings growth in fiscal 2019. Higher interest rates and lower than expected Snyder-Lance operating contribution weigh on the analyst's earnings expectations. 2. MannKind (MNKD) downgraded to Sell from Hold at Maxim by analyst Jason Kolbert, who said the company's Afrezza revenues of $4.5M were at the lower end of recently-lowered guidance and were " clearly disappointing given management's robust marketing plans". Kolbert added that the company has just $44M of cash remaining, having burned through about $120M last year. 3. Darling Ingredients (DAR) downgraded to Neutral from Buy at Goldman Sachs by analyst Adam Samuelson. While the company's Q4 results came in modestly above expectations, the analyst finds the outlook for roughly flat EBITDA in the base business despite recent growth investments disappointing. Samuelson sees a less attractive risk/reward for Darling post the Q4 results. Shares were also downgraded to Market Perform from Outperform at BMO Capital by analyst Kenneth Zaslow, who said his undamental view on the company has not changed, pointing to less compelling risk-reward based on limited upside in the stock price and some near-term headwinds. 4. Gibraltar Industries (ROCK) downgraded to Sector Weight from Overweight at KeyBanc by analyst Kenneth Zener, who said the risk to return is currently balanced. The analyst awais clarity on the company's next portfolio addition and wants to sees a "steady cadence of Solar EBIT margins." He believes, however, the Gibraltar is executing well post its Q4 results. 5. Mohawk (MHK) downgraded to Buy from Conviction Buy at Goldman Sachs. Analyst Samuel Eisner removed Mohawk from the Conviction Buy List citing near-term risks from rising rates and 1H18 risks from increasing costs and ramping capacity that could put a lid on shares near-term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AGN Allergan
$163.70

0.08 (0.05%)

03/05/18
CANT
03/05/18
INITIATION
Target $25
CANT
Overweight
Evolus initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen started Evolus (EOLS) with an Overweight rating and $25 price target. Physicians want a less costly alternative to Allergan's (AGN) Botox, Chen tells investors in a research note. She expects approval of DWP-450 before the end of the year and notes Evolus is planning to sell the neurotoxin at a 20%-25% discount to Botox.
03/05/18
RHCO
03/05/18
INITIATION
Target $24
RHCO
Buy
Evolus initiated with a Buy at SunTrust
SunTrust analyst John Boris initiated Evolus (EOLS) with a Buy rating and a price target of $24. Boris notes that the company is about its launch it first product DWP-450, targeting the $2B global aesthetic toxin market, adding that the treatment has been de-risked with comparable efficacy to Allergan's (AGN) Botox. The analyst anticipates regulatory approval from the FDA and a soft U.S. launch in Q4 of this year.
03/14/18
RBCM
03/14/18
NO CHANGE
RBCM
Outperform
RBC says Allergan sent clear message that all strategic options being evaluated
RBC Capital analyst Randall Stanicky said that Allergan Chairman and CEO Brent Saunders and new CFO Matt Walsh sent a "clear" message while presenting earlier at an investor conference that all strategic options are being evaluated "with a sense of urgency." This message, which he said is the one he had hoped to hear, will keep the asset sale/break-up debate in the stock, said Stanicky. The analyst, who expects the Street's focus on asset sales to pick up following this, keeps an Outperform rating on Allergan shares.
03/15/18
JPMS
03/15/18
NO CHANGE
Target $265
JPMS
Overweight
Allergan CEO comments on evaluating options a 'clear positive,' says JPMorgan
JPMorgan analyst Chris Schott views Allergan CEO Brent Saunders' comments yesterday on evaluating all options to create value as a "clear positive." The company is focusing on core business execution with a set of near-term pipeline opportunities while also examining other potential value-unlocking options for the business, Schott tells investors in a research note. The analyst says he has long argued that Allergan's core business is "significantly undervalued" and that any shift toward greater Botox/aesthetics exposure would result in a company that trades at a "distinctly higher multiple" than the current business. As such, he believes selling or spinning off assets could unlock value. Schott keeps an Overweight rating on Allergan with a $265 price target.
PEP PepsiCo
$108.74

-1.16 (-1.06%)

02/14/18
02/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PepsiCo (PEP) downgraded to In Line from Outperform at Evercore ISI with analyst Robert Ottenstein saying that while the company's dividend increase is "important and positive," he no longer expects the company to outperform in the beverage sector amid an "array of issues" at North America Beverage segment limiting upside performance. 2. Spark Therapeutics (ONCE) downgraded to Neutral from Overweight at JPMorgan with analyst Cory Kasimov saying he remains optimistic about the long-term outlook for the company, but notes the shares are now within 10% of his price target following the recent rally. 3. Chimerix (CMRX) downgraded to Underweight from Neutral at JPMorgan with analyst Jessica Fye saying with base-case timing for the AdAPT data well over a year away, the shares will underperform over the near term. 4. Avis Budget (CAR) downgraded to Sell from Neutral at Goldman Sachs with analyst David Tamberrino saying he believes transitory benefits from Hurricane recovery demand are waning, and headwinds from reduced residual values, higher interest rates, continued competition, and increased SG&A expenses will pressure Avis' earnings outlook. 5. Lexicon (LXRX) downgraded to Underweight from Neutral at JPMorgan with analyst Jessica Fye saying the Xermelo launch remains slow, and consensus estimates of $55M and $99M for 2018 and 2019 are too high. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/14/18
EVER
02/14/18
DOWNGRADE
EVER
In Line
PepsiCo downgraded to In Line from Outperform at Evercore ISI
02/14/18
EVER
02/14/18
DOWNGRADE
EVER
In Line
PepsiCo downgraded to In Line at Evercore ISI on NAB issues
As reported earlier, Evercore ISI analyst Robert Ottenstein downgraded PepsiCo to In Line from Outperform. The analyst says that while the company's dividend increase is "important and positive", he no longer expects the company to outperform in the beverage sector amid an "array of issues" at North America Beverage segment limiting upside performance. Ottenstein also points to rising commodity prices and expectations of the company to increase marketing expenses in NAB if results do not materialize. potentially putting downward pressure on the second half of 2018 earnings.
02/14/18
RHCO
02/14/18
NO CHANGE
Target $115
RHCO
Hold
PepsiCo price target lowered to $115 from $125 at SunTrust
SunTrust analyst William Chappell lowered his price target on PepsiCo to $115 from $125, saying it is surprising that investors are giving the company a pass on its decision to reinvest a majority of its tax savings back into the business. The analyst adds that while PepsiCo's North America Beverage segment organic sales improved sequentially to -3% from -5%, they remain below the multi-year track record of low-single-digit growth. While the company has plans for product innovation and brand building, the analyst contends that the flat growth remains a concern. Chappell keeps his Hold rating on PepsiCo.
GM General Motors
$37.58

0.69 (1.87%)

03/09/18
DBAB
03/09/18
NO CHANGE
DBAB
Deutshe Bank sees buying opportunities in Autos & Auto Parts
Deutsche Bank analyst Rod Lache attributes the recent selloff in Auto Industry stocks a confluence of factors, including rising rates, rising commodities/tariffs, and rising NAFTA risks. These represent a "triple-threat that has led to a resurgence of cyclical concerns," Lache tells investors in a research note. The analyst, while admitting limited visibility into the "most significant of these," the outlook for NAFTA, believes that investor concerns are overdone. He's a buyer of General Motors (GM), American Axle (AXL), and Lear (LEA) on weakness.
03/13/18
MSCO
03/13/18
NO CHANGE
MSCO
Morgan Stanley compares automakers to Facebook, Apple in 'Auto 2.0' model
Morgan Stanley analyst Adam Jonas noted that auto companies' valuations have compressed to extremely low levels, but he believes that a move from a vehicle ownership model to a transportation subscriber model could expand the revenue opportunities for the potential "tollkeepers" for the monetization of content and data by "nearly an order of magnitude." Looking at U.S. technology leaders Facebook (FB) and Apple (AAPL), which are both valued on their installed base/subscriber models, can "offer valuable clues" regarding the opportunity for General Motors (GM) and other auto OEMs, said Jonas. Viewing the OEMs though the lens of a subscription model, which should be less cyclical and potentially less capital intensive over time than the current auto model, is relevant to analyzing auto stocks, according to Jonas, who adds that it is still too early to call a winner or loser in "Auto 2.0." Other publicly traded legacy automakers include Fiat Chrysler (FCAU), Ford (F), Honda (HMC), Nissan (NSANY), Toyota (TM), Volkswagen (VLKAY) and Daimler (DDAIF).
03/14/18
MSCO
03/14/18
NO CHANGE
MSCO
Morgan Stanley raises U.S. auto sales forecasts through 2021
Morgan Stanley analyst Adam Jonas raised his U.S. seasonally adjusted annual rate, or SAAR, forecast for automakers by an average of 850,000 units from 2018 through 2021, which represents slightly more than a 5% increase from his prior forecast. However, his average U.S. SAAR forecast is still well below last year's 17.3M units and 8% under the cyclical high of 17.6M units in 2016. Jonas points to U.S. tax reform and "relatively stable" recent trends in auto sales and credit as reasons for the hike, noting that while infrastructure action from the federal government could be a material positive, it is not explicitly in his new forecast. Adding that the higher view has a net positive impact on estimates and price targets for exposed auto Original Equipment Manufacturers, or OEMs, and suppliers, Jonas raised his price targets on General Motors (GM), Asbury Automotive (ABG), AutoNation (AN), Group 1 Automotive (GPI), Lithia Motors (LAD), Penske Automotive (PAH), Sonic Automotive (SAH) and Ford (F). He also double upgraded Ford, to Overweight from Underweight, this morning.
02/12/18
SBSH
02/12/18
NO CHANGE
Target $70
SBSH
Buy
General Motors price target raised to $70 from $60 at Citi
Citi analyst Itay Michaeli raised his price target for General Motors to $70 from $60 citing greater confidence in his long-term potential upside case of $134 per share. The carmaker closed Friday up 70c to $41.46. The analyst views his new price target as "arguably conservative." The $70 per share target does not contemplate the "potential game-changing implications" of GM's leadership in autonomous vehicles as a Network, or robotaxis, Michaeli tells investors in a research note. The analyst believes GM's exposure to pickup trucks and robotaxi networks are "overlooked/misunderstood narratives." He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

02:25
04/27/18
04/27
02:25
04/27/18
02:25
General news
FX Update: Dollar majors are at near net unchanged levels »

FX Update: Dollar majors…

02:05
04/27/18
04/27
02:05
04/27/18
02:05
General news
Asian Market Wrap: »

Asian Market Wrap: The…

AAPL

Apple

$164.22

0.41 (0.25%)

20:43
04/26/18
04/26
20:43
04/26/18
20:43
Periodicals
Apple to make 8M iPhone X smartphones in Q2, AI reports »

Apple is expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

EWY

iShares MSCI South Korea Index Fund

$75.21

1.94 (2.65%)

, SPY

SPDR S&P 500 ETF Trust

$266.23

2.59 (0.98%)

20:36
04/26/18
04/26
20:36
04/26/18
20:36
General news
N. Korea's Kim Jong Un shakes hands with S. Korea's leader Moon, Bloomberg says »

The report states Kim…

EWY

iShares MSCI South Korea Index Fund

$75.21

1.94 (2.65%)

SPY

SPDR S&P 500 ETF Trust

$266.23

2.59 (0.98%)

EWJ

iShares MSCI Japan Index Fund

$60.95

0.38 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$80.86

1.35 (1.70%)

, CVX

Chevron

$124.22

1.53 (1.25%)

20:25
04/26/18
04/26
20:25
04/26/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

XOM

Exxon Mobil

$80.86

1.35 (1.70%)

CVX

Chevron

$124.22

1.53 (1.25%)

SNY

Sanofi

$40.37

0.265 (0.66%)

CHTR

Charter

$297.00

-3.37 (-1.12%)

CL

Colgate-Palmolive

$66.60

0.18 (0.27%)

PSX

Phillips 66

$113.00

3.18 (2.90%)

SPG

Simon Property

$150.18

3.4 (2.32%)

D

Dominion

$65.04

0.22 (0.34%)

LYB

LyondellBasell

$106.51

1.11 (1.05%)

MCO

Moody's

$164.56

1.955 (1.20%)

WY

Weyerhaeuser

$36.64

0.46 (1.27%)

COL

Rockwell Collins

$133.00

-0.26 (-0.20%)

HMC

Honda

$34.78

0.18 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 15

    May

  • 20

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 30

    May

  • 25

    Jun

  • 20

    Oct

  • 28

    Jan

PROV

Provident Financial

$18.34

0.1 (0.55%)

20:01
04/26/18
04/26
20:01
04/26/18
20:01
Hot Stocks
Provident Financial announces additional stock repurchase plan for 373K shares »

Provident Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

WAL

Western Alliance

$59.31

0.2 (0.34%)

19:55
04/26/18
04/26
19:55
04/26/18
19:55
Hot Stocks
Western Alliance names Barbara Kennedy as Chief HR Officer »

Western Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

NOV

National Oilwell

$38.65

0.365 (0.95%)

19:54
04/26/18
04/26
19:54
04/26/18
19:54
Earnings
National Oilwell reports Q1 EPS (18c), consensus (5c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 01

    May

  • 07

    May

  • 22

    May

XRX

Xerox

$30.42

-0.21 (-0.69%)

19:30
04/26/18
04/26
19:30
04/26/18
19:30
Hot Stocks
Breaking Hot Stocks news story on Xerox »

Xerox rises 1.9%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

SWN

Southwestern Energy

$4.52

0.055 (1.23%)

19:29
04/26/18
04/26
19:29
04/26/18
19:29
Earnings
Southwestern Energy reports Q1 adjusted EPS 28c, consensus 25c »

Reports Q1 revenue $920M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 22

    May

  • 25

    Jun

XRX

Xerox

$30.42

-0.21 (-0.69%)

, FUJIY

Fujifilm

19:26
04/26/18
04/26
19:26
04/26/18
19:26
Periodicals
Xerox, Fujifilm reopen merger talks, Reuters reports »

Xerox (XRX) chairman…

XRX

Xerox

$30.42

-0.21 (-0.69%)

FUJIY

Fujifilm

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

SBSI

Southside Bancshares

$35.31

-0.32 (-0.90%)

19:19
04/26/18
04/26
19:19
04/26/18
19:19
Hot Stocks
Southside Bancshares discontinues stock dividend »

The Board decided to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 09

    May

GSHD

Goosehead Insurance

19:11
04/26/18
04/26
19:11
04/26/18
19:11
Syndicate
Goosehead Insurance 8.53M share IPO priced at $10.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

DOCU

Docusign

19:09
04/26/18
04/26
19:09
04/26/18
19:09
Syndicate
Docusign 21.7M share IPO priced at $29.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

SMAR

Smartsheet

19:05
04/26/18
04/26
19:05
04/26/18
19:05
Syndicate
Smartsheet 11.63M share IPO priced at $15.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

NTDOY

Nintendo

19:04
04/26/18
04/26
19:04
04/26/18
19:04
Hot Stocks
Nintendo partners with Cygames on gaming app for smart devices »

Nintendo and Cygames…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPE

Expedia

$106.42

-2 (-1.84%)

, BJRI

BJ's Restaurants

$49.55

0.95 (1.95%)

19:03
04/26/18
04/26
19:03
04/26/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

EXPE

Expedia

$106.42

-2 (-1.84%)

BJRI

BJ's Restaurants

$49.55

0.95 (1.95%)

AMZN

Amazon.com

$1,517.96

57.79 (3.96%)

SIVB

SVB Financial

$257.67

0.06 (0.02%)

CHGG

Chegg

$21.67

-0.41 (-1.86%)

BIDU

Baidu

$239.14

7.7 (3.33%)

INTC

Intel

$53.08

1.69 (3.29%)

KN

Knowles

$11.15

-0.175 (-1.55%)

EMN

Eastman Chemical

$105.93

0.835 (0.79%)

ELY

Callaway Golf

$16.82

0.12 (0.72%)

MSFT

Microsoft

$94.25

1.83 (1.98%)

BYD

Boyd Gaming

$33.45

-0.301 (-0.89%)

NUS

Nu Skin

$72.15

0.55 (0.77%)

MAT

Mattel

$13.99

0.51 (3.78%)

S

Sprint

$6.00

-0.04 (-0.66%)

OAS

Oasis Petroleum

$10.61

-0.035 (-0.33%)

FLEX

Flex

$16.64

0.04 (0.24%)

LOGM

LogMeln

$119.70

2.45 (2.09%)

CLD

Cloud Peak

X

U.S. Steel

$37.65

0.61 (1.65%)

AMKR

Amkor Technology

$9.12

0.31 (3.52%)

CUBE

CubeSmart

$28.40

0.705 (2.55%)

SBUX

Starbucks

$59.38

1.66 (2.88%)

WDC

Western Digital

$87.91

2.03 (2.36%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 07

    May

  • 08

    May

  • 08

    May

  • 09

    May

  • 29

    May

  • 04

    Jun

  • 11

    Jun

  • 24

    Sep

WELL

Welltower

$50.01

-0.445 (-0.88%)

, QCP

Quality Care Properties

$21.70

-1.02 (-4.49%)

19:01
04/26/18
04/26
19:01
04/26/18
19:01
Recommendations
Welltower, Quality Care Properties analyst commentary at MUFG »

Welltower price target…

WELL

Welltower

$50.01

-0.445 (-0.88%)

QCP

Quality Care Properties

$21.70

-1.02 (-4.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 03

    May

  • 04

    May

MNOV

MediciNova

19:01
04/26/18
04/26
19:01
04/26/18
19:01
Hot Stocks
MediciNova to present additional clinical data from MN-166 trial at AAN »

MediciNova announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SBSI

Southside Bancshares

$35.31

-0.32 (-0.90%)

18:58
04/26/18
04/26
18:58
04/26/18
18:58
Hot Stocks
Southside Bancshares raises quarterly dividend 7.1% to 30c per share »

The cash dividend is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 09

    May

SFNC

Simmons First National

$30.38

-0.125 (-0.41%)

18:50
04/26/18
04/26
18:50
04/26/18
18:50
Hot Stocks
Simmons First National exec sells 50,000 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 24

    Sep

ISBC

Investors Bancorp

$13.55

-0.05 (-0.37%)

18:46
04/26/18
04/26
18:46
04/26/18
18:46
Earnings
Investors Bancorp reports Q1 EPS 20c, consensus 18c »

Reports Q1 NII $172.48M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 14

    May

BIDU

Baidu

$239.14

7.7 (3.33%)

18:24
04/26/18
04/26
18:24
04/26/18
18:24
Hot Stocks
Breaking Hot Stocks news story on Baidu »

Baidu up 6.4% to $254.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

OAS

Oasis Petroleum

$10.61

-0.035 (-0.33%)

, WPG

Washington Prime

$6.40

0.44 (7.38%)

18:14
04/26/18
04/26
18:14
04/26/18
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

Oasis Petroleum (OAS)…

OAS

Oasis Petroleum

$10.61

-0.035 (-0.33%)

WPG

Washington Prime

$6.40

0.44 (7.38%)

BH

Biglari

$422.15

7.4 (1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 07

    May

  • 08

    May

SBUX

Starbucks

$59.38

1.66 (2.88%)

18:13
04/26/18
04/26
18:13
04/26/18
18:13
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks not seeing SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.